Skip to main content
WeRide Inc. logo

WeRide Inc. — Investor Relations & Filings

Ticker · 800 LEI · 254900R1B7IWBCPDQ262 HKEX Transportation and storage
Filings indexed 1,050 across all filing types
Latest filing 2025-10-06 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 800

About WeRide Inc.

http://www.weride.ai

WeRide Inc. is a commercial-stage global technology leader specializing in the research, development, and large-scale deployment of autonomous driving solutions, ranging from Level 2 (WePilot 3.0 ADAS) to Level 4 capabilities. The company offers a comprehensive portfolio of autonomous vehicles designed for various mobility and logistics applications, including Robotaxi, Robobus, Robovan, and Robosweeper. WeRide is recognized as a pioneer in the industry, operating in over 40 cities across 11 countries and holding autonomous driving permits in seven countries globally. Its core products, such as the Robotaxi, have launched large-scale commercial operations in regions like China and the UAE. WeRide leverages its proprietary technology stack to deliver safe, reliable, and scalable driverless solutions for urban transformation.

Recent filings

Filing Released Lang Actions
FURTHER EXTENSION OF LONG STOP DATES
Capital/Financing Update Classification · 1% confidence The document is an exchange announcement by a Hong Kong listed company regarding the further extension of long stop dates under two subscription agreements for new share issuances. It details the amendments to the subscription agreements to extend the deadline for fulfilling conditions precedent, which is clearly a corporate financing update relating to capital raising. This fits squarely under the category for updates on fundraising and financing activities. Hence, the appropriate classification is Capital/Financing Update (CAP).
2025-10-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Share Issue/Capital Change Classification · 1% confidence The document is a monthly return (Form FF301) filed with HKEX under Listing Rule 13.25C/17.27C detailing movements in authorised share capital, issued shares, treasury shares, convertibles, and other capital items for the month. It constitutes a formal announcement of share capital changes rather than an earnings release, management commentary, or repurchase notice. Therefore, it falls under the Share Issue/Capital Change category (SHA).
2025-10-03 English
QUARTERLY UPDATES ON THE IMPLEMENTATION OF ACTION PLANS TO RESOLVE THE DISCLAIMER OF OPINION
Capital/Financing Update Classification · 1% confidence The document is a Hong Kong Exchange listing announcement providing an update on the implementation of action plans to resolve a going‐concern disclaimer. The primary content focuses on financing measures: restructuring convertible bonds, equity subscriptions, and share placements (fundraising and capital structure changes). It is not a full annual or interim report, but rather an update on capital/financing activities. This matches the definition for a Capital/Financing Update (CAP).
2025-09-30 English
(1) CHANGE OF COMPANY NAME&#x3b; (2) CHANGE OF STOCK SHORT NAME&#x3b; (3) CHANGE OF COMPANY LOGO&#x3b; and (4) CHANGE OF COMPANY WEBSITE
Regulatory Filings Classification · 1% confidence The document is an official Stock Exchange announcement regarding administrative changes to the company (name change, stock short name change, logo and website update). It is not a financial report, management restructure, dividend notice, or other specific transaction notice. It fits the fallback category for general regulatory announcements. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-09-29 English
FURTHER EXTENSION OF LONG STOP DATES
Capital/Financing Update Classification · 1% confidence The document is a public announcement regarding the extension of long stop dates under two subscription agreements for share issuances. It is not a full report (10-K/IR), board change (MANG), dividends (DIV), or buyback (POS). It updates the terms of a capital-raising transaction (share subscriptions). Therefore it falls under Capital/Financing Update (CAP).
2025-09-16 English
LAPSE OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 1% confidence The document is an Exchange announcement from Innovative Pharmaceutical Biotech Limited regarding the lapse of a placing agreement for new share issuance under the company’s general mandate. It updates investors on a planned equity financing that has now ceased to proceed. This falls under announcements concerning new share issues or capital changes. Therefore, the appropriate filing category is Share Issue/Capital Change (SHA).
2025-09-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.